Evommune
Palo Alto, CA
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases.
evommune.comCompany Details
Founded
- 2020
Employees
- Between 20 - 50 employees
Raised
- $349,799,936
Headquarters Location
- Palo Alto, CA
Public
- No
Acquired
- No
CEO
Luis Pena
Founders
- Hans HoflandLuis Pena
Company Collections
These are collections Evommune is a part of. Click on the collection name to view similar companies.
Evommune's Industries
Evommune's Tech Stack
Evommune Headquarters Location
Palo Alto, CA 94306
Total Amount Raised: $349,799,936
Evommune Funding Rounds
Post Ipo Equity
$125,000,000
Series Unknown
$81,799,952
Series Unknown
$81,799,952
IPO
Unknown
Series C
$115,000,000
Series C
$115,000,000
Series C Investors
RA Capital ManagementSectoral Asset ManagementAllostery InvestmentsPivotal bioVenture PartnersADAR1 Capital ManagementVerition Fund ManagementAmplitude VenturesLSPB CapitalAndera PartnersFemHealth VenturesSymBiosisAvego Bioscience CapitalMarshall WaceLongwood FundRTW InvestmentsNEXTBio CapitalOscar & PaulSeries B
$7,500,000
Series B
$7,500,000
Series B Investors
Verition Fund ManagementSeries B
$50,000,000
Series B
$50,000,000
Series B Investors
Arix BioscienceLSPSymBiosisAmplitude VenturesAndera PartnersPivotal bioVenture PartnersSeries A
$83,000,000
Series A
$83,000,000
Series A Investors
Pivotal bioVenture PartnersAndera PartnersLSP BioVenturesSeed
$12,500,000
Seed
$12,500,000
Seed Investors
Pivotal bioVenture Partners
Funding info provided by Diffbot.
Evommune Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Evommune.